Takeda’s Takhzyro approved in Japan to prevent rare genetic disorder
The Japanese regulator’s approval was based on results from global Phase 3 HELP study, Phase 3 HELP OLE…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Mar 22
The Japanese regulator’s approval was based on results from global Phase 3 HELP study, Phase 3 HELP OLE…
25 Mar 22
The breakthrough designation is based on the positive results from a proof-of-concept, Phase 2a study in healthy adults…
25 Mar 22
The EMA recommendation is based on the Phase 3 PROVENT trial, in which Evusheld significantly reduced the risk…
23 Mar 22
Covovax is said to be the first protein-based recombinant Covid-19 vaccine authorised for adolescents in India, based on…
21 Mar 22
Ztalmy is claimed to be the first and only FDA approved therapy for seizures related to CDKL5 deficiency…
17 Mar 22
It is said to be the first indication for Rinvoq in gastroenterology and the FDA approval in the…
17 Mar 22
Breyna is indicated for asthma patients, aged six years and above, along with maintenance treatment of patients with…
14 Mar 22
Lynparza is said to be the first and only FDA approved adjuvant therapy for patients with gBRCAm, HER2-negative…
14 Mar 22
The NMPA approval was based on positive results from a single-arm, multi-centre, open-label Phase 2 trial that evaluated…
07 Mar 22
In the Phase 3 CheckMate -816 trial, Opdivo plus platinum-doublet chemotherapy showed superior outcomes compared to platinum-doublet chemotherapy…